55 results
Page 3 of 3
S-4/A
EX-10.54
zn99kgz s79w7vz129
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4/A
ys2t58r zhhy6w3cs59s
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4
wvpq8
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
8-K
EX-2.1
sog ggxz2
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
8-K
EX-2.2
lvblbhh944 kuswl5
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
425
EX-2.1
kncr6i68h6v
21 Jan 20
Business combination disclosure
9:19am
425
EX-2.2
on03qdux4av mrzf
21 Jan 20
Business combination disclosure
9:19am
8-K
EX-10.2
71hi8v9xmu
29 May 18
Ritter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial Officer
6:11am
10-Q
EX-10.3
s2ho1rai27oe1u3wj
12 Aug 15
Quarterly report
12:00am
10-Q
EX-10.4
7entm6
12 Aug 15
Quarterly report
12:00am
DRS
4eoewsb clp9f1xj
29 Jan 15
Draft registration statement
12:00am